Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-016193
Filing Date
2013-03-19
Accepted
2013-03-19 17:16:35
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v336896_10k.htm 10-K 649536
2 EXHIBIT 10.2A v336896_ex10-2a.htm EX-10.2A 49293
3 EXHIBIT 10.2B v336896_ex10-2b.htm EX-10.2B 12687
4 EXHIBIT 10.3B v336896_ex10-3b.htm EX-10.3B 10490
5 EXHIBIT 10.4 v336896_ex10-4.htm EX-10.4 81576
6 EXHIBIT 10.5 v336896_ex10-5.htm EX-10.5 54374
7 EXHIBIT 10.11A v336896_ex10-11a.htm EX-10.11A 40118
8 EXHIBIT 11B v336896_ex10-11b.htm EX-10.11B 43530
9 EXHIBIT 21.1 v336896_ex21-1.htm EX-21.1 3330
10 EXHIBIT 23.1 v336896_ex23-1.htm EX-23.1 2737
11 EXHIBIT 31.1 v336896_ex31-1.htm EX-31.1 10623
12 EXHIBIT 32.1 v336896_ex32-1.htm EX-32.1 4165
  Complete submission text file 0001144204-13-016193.txt   963553
Mailing Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024
Business Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024 626-227-1630
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52991 | Film No.: 13702681
SIC: 6770 Blank Checks